New Members and First Time Conference Attendees Meet-Up
6:00 PM – 7:00 PM
New Members and First Time Conference Attendees Meet-Up
Location: Lounge 1-2, Longhorn Hall D, Level 1
6:00 PM – 7:00 PM
Region X Meeting (AL, FL, KY, MS, PR, TN, VI)
6:00 PM – 7:00 PM
Region X Meeting (AL, FL, KY, MS, PR, TN, VI)
Location: San Antonio 4-6, Level 3
6:30 PM – 7:00 PM
Primary Care & Family Medicine Special Interest Group Meet-Up
6:30 PM – 7:00 PM
Primary Care & Family Medicine Special Interest Group Meet-Up
Location: Lounge 3, Longhorn Hall D, Level 1
6:30 PM – 7:00 PM
Women & Substance Use Special Interest Group Meet-Up
6:30 PM – 7:00 PM
Women & Substance Use Special Interest Group Meet-Up
Location: Ft. Worth 5-7, Level 3
6:30 PM – 8:00 PM
President's Donor Reception
6:30 PM – 8:00 PM
President's Donor Reception
Location: Yellow Rose Ballroom, Level 1
7:00 PM – 8:00 PM
Concurrent Sessions #1
7:00 PM – 8:00 PM
Addiction Medicine Fellowships – the Key to Building A High Quality Workforce Developed in Collaboration with the American College of Academic Addiction Medicine
Becoming Certified in Addiction Medicine and How to Continue That Certification Developed in Collaboration with the American Board of Preventive Medicine
Bridging the Gap between Science and Clinical Practice Developed in Collaboration with the Agency for Healthcare Research and Quality and the National Institutes of Health
Presenter: Isabelle Fox – Wright State University Boonshoft School of Medicine
Non-presenting author: Sydney M. Silverstein, PhD – Wright State University Boonshoft School of Medicine
Workshop Session
3:00 PM – 4:15 PM
Integrating Addiction Prevention and Early Treatment in Primary Care Settings: Advances in Research and Practice Developed in Collaboration with the National Institute on Alcohol Abuse and Alcoholism
Location: Grapevine 4-6, Level 3
Presenter: Deidra Y. Roach, MD – National Institute on Alcohol Abuse and Alcoholism
Presenter: Amy Leibowitz, PsyD – Kaiser Permanente Northern California, Division of Research, Center for Addiction and Mental Health Research
Co-occurring Disorders: Integrating Prevention, Intervention and Evidence Developed in Collaboration with the Substance Abuse and Mental Health Services Administration
Prescribing Medications for Alcohol Use Disorder for Individuals with Liver Disease Developed in Collaboration with the Providers Clinical Support System - Medications for Alcohol Use Disorder
Naloxone, Nalmefene, and Naltrexone: Is There a Need for Three Opioid Antagonists? Developed in Collaboration with the American College of Medical Toxicology